Pharmacogenomics studies how genes affect a person’s response to medications by combining the fields of clinical pharmacology (the science of drugs) and genomics (the study of genes and what they do). The goal of pharmacogenomics is to incorporate genomic information into medication prescribing protocols.
Every doctor knows from experience that some drugs do not work the same for everyone. Now, we have the knowledge to predict and avoid some of these issues and lessen the financial burden of hospitalizations and deaths caused by adverse drug reactions. Pharmacogenomics plays a vital role in helping to predict the efficacy of a medication and its dosing and to prevent adverse drug reactions.
To get the most out of pharmacogenomics, you need the technology to support turning genetic data into actionable data. As a SaaS provider, Translational Software is at the forefront of pharmacogenomics, offering solutions that are:
"Integrating Translational Software’s PGx knowledge base within our e-prescribing platform allows us to deliver an in-workflow, evidence-based approach to medication prescribing that can be used as part of routine care."
President of DrFirst
"Translational Software understands pharmacogenomic testing better than anyone else in the field, and they were able to create a platform that seamlessly delivered on our vision."
Chief Medical Officer at 2bPrecise LLC
"Translational Software has taken the pioneering step of implementing the first pharmacogenomics solution that employs FHIR genomics for optimizing the prescription of patient medications, and has been a real leader in this arena."
Gil Alterovitz, Ph.D., a Harvard Medical School professor and co-chair of HL7’s Clinical Genomics Work Group
